Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs
Hemophilia: One gene therapy fits all A strategy to restore the expression of the gene encoding blood clotting factor VIII (FVIII) offers new hope to patients with hemophilia A. Hemophilia A is a rare bleeding disorder caused by a variety of mutations in the FVIII gene which affect the function of F...
Main Authors: | Jin Jea Sung, Chul-Yong Park, Joong Woo Leem, Myung Soo Cho, Dong-Wook Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-04-01
|
Series: | Experimental and Molecular Medicine |
Online Access: | https://doi.org/10.1038/s12276-019-0243-1 |
Similar Items
-
Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCs
by: Do-Hun Kim, et al.
Published: (2025-01-01) -
Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived From F8-Modified iPSCs
by: Liyan Qiu, et al.
Published: (2021-02-01) -
ssODN-Mediated In-Frame Deletion with CRISPR/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs
by: Zhiqing Hu, et al.
Published: (2019-09-01) -
Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A mice
by: Sajjad Afraz, et al.
Published: (2022-11-01) -
Generation of a gene edited hemophilia A patient-derived iPSC cell line, YCMi001-B-1, by targeted insertion of coagulation factor FVIII using CRISPR/Cas9
by: Jin Jea Sung, et al.
Published: (2020-10-01)